Liver neoplasms in methylmalonic aciduria: An emerging complication

• Published in: Journal of inherited metabolic disease Vol. 42; no. 5; pp. 793 - 802
• Main Authors: Forny, Patrick, Hochuli, Michel, Rahman, Yusof, Deheragoda, Maesha, Weber, Achim, Baruteau, Julien, Grunewald, Stephanie
• Format: Journal Article
• Language: English
• Published: Hoboken, USA John Wiley & Sons, Inc 01.09.2019
• Subjects: hepatoblastoma; hepatocellular carcinoma; liver; methylmalonic aciduria; mitochondrial dysfunction; oncogenesis; oxidative stress; hepatoblastoma; liver; oncogenesis; methylmalonic aciduria; mitochondrial dysfunction; hepatocellular carcinoma; oxidative stress
• ISSN: 0141-8955; 1573-2665
• DOI: 10.1002/jimd.12143

Methylmalonic aciduria (MMA) is an inherited metabolic disease caused by methylmalonyl‐CoA mutase deficiency. Early‐onset disease usually presents with a neonatal acute metabolic acidosis, rapidly causing lethargy, coma, and death if untreated. Late‐onset patients have a better prognosis but develop common long‐term complications, including neurological deterioration, chronic kidney disease, pancreatitis, optic neuropathy, and chronic liver disease. Of note, oncogenesis has been reported anecdotally in organic acidurias. Here, we present three novel and two previously published cases of MMA patients who developed malignant liver neoplasms. All five patients were affected by a severe, early‐onset form of isolated MMA (4 mut0, 1 cblB subtype). Different types of liver neoplasms, that is, hepatoblastoma and hepatocellular carcinoma, were diagnosed at ages ranging from infancy to adulthood. We discuss pathophysiological hypotheses involved in MMA‐related oncogenesis such as mitochondrial dysfunction, impairment of tricarboxylic acid cycle, oxidative stress, and effects of oncometabolites. Based on the intriguing occurrence of liver abnormalities, including neoplasms, we recommend close biochemical and imaging monitoring of liver disease in routine follow‐up of MMA patients.